These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8392085)

  • 1. Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.
    Kristjansson K; Rut AR; Hewison M; O'Riordan JL; Hughes MR
    J Clin Invest; 1993 Jul; 92(1):12-6. PubMed ID: 8392085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.
    Malloy PJ; Hochberg Z; Tiosano D; Pike JW; Hughes MR; Feldman D
    J Clin Invest; 1990 Dec; 86(6):2071-9. PubMed ID: 2174914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
    Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
    J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures.
    Rut AR; Hewison M; Kristjansson K; Luisi B; Hughes MR; O'Riordan JL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):581-90. PubMed ID: 7828346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Yagi H; Ozono K; Miyake H; Nagashima K; Kuroume T; Pike JW
    J Clin Endocrinol Metab; 1993 Feb; 76(2):509-12. PubMed ID: 8381803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
    Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
    Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
    Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
    Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families.
    Ritchie HH; Hughes MR; Thompson ET; Malloy PJ; Hochberg Z; Feldman D; Pike JW; O'Malley BW
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9783-7. PubMed ID: 2557627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D.
    Nguyen TM; Adiceam P; Kottler ML; Guillozo H; Rizk-Rabin M; Brouillard F; Lagier P; Palix C; Garnier JM; Garabedian M
    J Bone Miner Res; 2002 Sep; 17(9):1728-37. PubMed ID: 12211444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
    Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
    Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
    Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
    J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
    Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
    J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor.
    Malloy PJ; Wang J; Srivastava T; Feldman D
    Mol Genet Metab; 2010 Jan; 99(1):72-9. PubMed ID: 19815438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene.
    Hewison M; Rut AR; Kristjansson K; Walker RE; Dillon MJ; Hughes MR; O'Riordan JL
    Clin Endocrinol (Oxf); 1993 Dec; 39(6):663-70. PubMed ID: 8287584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.